Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141955 |
| CAS No | NA |
| Mol.F. | C23H29Cl2N5O |
| Mol.Wt. | 462.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141956 |
| CAS No | 53602-74-7 |
| Mol.F. | C13H13N3O4 |
| Mol.Wt. | 275.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141957 |
| CAS No | NA |
| Mol.F. | C11H11N3O3 |
| Mol.Wt. | 233.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141958 |
| CAS No | 68807-89-6 |
| Mol.F. | C11H11N3O3 |
| Mol.Wt. | 233.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141959 |
| CAS No | NA |
| Mol.F. | C12H17ClN2O2 |
| Mol.Wt. | 256.7 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141960 |
| CAS No | 13256-23-0 |
| Mol.F. | C8H11N3O |
| Mol.Wt. | 165.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141961 |
| CAS No | NA |
| Mol.F. | C20H25N3O6 |
| Mol.Wt. | 403.4 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141962 |
| CAS No | NA |
| Mol.F. | C17H16Cl2N2O |
| Mol.Wt. | 335.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141963 |
| CAS No | 2659259-64-8 |
| Mol.F. | C15H14N2O |
| Mol.Wt. | 238.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141964 |
| CAS No | NA |
| Mol.F. | C27H27F2N7O3 |
| Mol.Wt. | 535.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141965 |
| CAS No | NA |
| Mol.F. | C19H18Br2N6O3 |
| Mol.Wt. | 538.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141966 |
| CAS No | NA |
| Mol.F. | C15H18BrN5O5S |
| Mol.Wt. | 460.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141967 |
| CAS No | NA |
| Mol.F. | C19H19Br2N7O5S |
| Mol.Wt. | 617.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141968 |
| CAS No | NA |
| Mol.F. | C28H30Br2N10O8S2 |
| Mol.Wt. | 858.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141969 |
| CAS No | NA |
| Mol.F. | C13H13BrClN5O3S |
| Mol.Wt. | 434.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141970 |
| CAS No | NA |
| Mol.F. | C13H15N3O |
| Mol.Wt. | 229.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |